Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-07

Clinical Trial Update: Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

View source ↗

Summary

This clinical trial update notes a biomarker-driven study aimed at dissecting ALS phenotypes is currently recruiting, including conditions such as Amyotrophic L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istituto Auxologico Italiano | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Status: RECRUITING